A summary of mechanistic hypotheses of gabapentin pharmacology

Epilepsy Research
C P TaylorL Singh

Abstract

Although the cellular mechanisms of pharmacological actions of gabapentin (Neurontin) remain incompletely described, several hypotheses have been proposed. It is possible that different mechanisms account for anticonvulsant, antinociceptive, anxiolytic and neuroprotective activity in animal models. Gabapentin is an amino acid, with a mechanism that differs from those of other anticonvulsant drugs such as phenytoin, carbamazepine or valproate. Radiotracer studies with [14C]gabapentin suggest that gabapentin is rapidly accessible to brain cell cytosol. Several hypotheses of cellular mechanisms have been proposed to explain the pharmacology of gabapentin: 1. Gabapentin crosses several membrane barriers in the body via a specific amino acid transporter (system L) and competes with leucine, isoleucine, valine and phenylalanine for transport. 2. Gabapentin increases the concentration and probably the rate of synthesis of GABA in brain, which may enhance non-vesicular GABA release during seizures. 3. Gabapentin binds with high affinity to a novel binding site in brain tissues that is associated with an auxiliary subunit of voltage-sensitive Ca2+ channels. Recent electrophysiology results suggest that gabapentin may modulate certain ty...Continue Reading

References

Sep 1, 1991·British Journal of Pharmacology·L SinghG N Woodruff
Mar 1, 1991·Neurochemical Research·M G Erlander, A J Tobin
Jul 1, 1991·Neuron·M G ErlanderA J Tobin
Feb 1, 1990·Pain·Helen Wheeler-AcetoAlan Cowan
Oct 1, 1987·Nature·A C Foster, G E Fagg
Jan 1, 1989·Psychopathology·C L BroekkampA M Van Delft
Jan 1, 1989·British Journal of Clinical Pharmacology·L GramA Schousboe
Jan 1, 1988·Journal of Neural Transmission·M L RaoS Krätzschmar
Jan 1, 1994·Annual Review of Neuroscience·R L Macdonald, R W Olsen
Jan 1, 1995·Annual Review of Biochemistry·W A Catterall
May 1, 1995·Journal of Pain and Symptom Management·G A MellickL B Mellick
Jul 13, 1995·Nature·M J DuringD D Spencer
Aug 1, 1995·Journal of Neurochemistry·J D Rothstein, R W Kuncl
Mar 14, 1994·Neuroscience Letters·J D Kocsis, O Honmou
Jan 1, 1994·Annual Review of Neuroscience·F HofmannV Flockerzi
Nov 15, 1993·European Journal of Pharmacology·R J ThurlowG N Woodruff
Feb 15, 1993·European Journal of Pharmacology·N Suman-ChauhanG N Woodruff
Feb 15, 1993·European Journal of Pharmacology·D R HillG N Woodruff
Mar 15, 1993·European Journal of Pharmacology·T KusamaG R Uhl
Jan 1, 1993·Annual Review of Pharmacology and Toxicology·N G Bowery

❮ Previous
Next ❯

Citations

Dec 7, 2000·Mental Retardation and Developmental Disabilities Research Reviews·J M Pellock, L D Morton
Aug 6, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·W OndoJ Jankovic
Oct 8, 2004·Biomedical Chromatography : BMC·Cristiana GambelungheMaria Vittoria Ambrosini
Dec 26, 2001·Depression and Anxiety·M E LaytonS R Dager
Apr 6, 2004·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Chandra Kant PandeyPrabhat Kumar Singh
Sep 1, 2005·Naunyn-Schmiedeberg's Archives of Pharmacology·Jarogniew J Luszczki, Stanislaw J Czuczwar
Dec 13, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·B BrawekT J Feuerstein
Nov 13, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·B BrawekT J Feuerstein
Mar 31, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·M KammererThomas J Feuerstein
Aug 21, 2008·Aesthetic Plastic Surgery·Alan A ParsaF Don Parsa
Oct 27, 2004·Journal of Neurology·K HahnUNKNOWN German Neuro-AIDS Working Group
Dec 1, 2005·Current Diabetes Reports·Roy Freeman
Jul 4, 2002·Current Pain and Headache Reports·Rie Suzuki, Anthony H Dickenson
Jan 15, 2003·Current Pain and Headache Reports·Miroslav Backonja
Feb 13, 2009·Current Treatment Options in Neurology·Barrington G BurnettCharlotte J Sumner
Sep 18, 2007·Journal of Molecular Neuroscience : MN·Jamil Ahsan Kazi, Chen Fun Gee
Aug 25, 2010·Journal of Molecular Neuroscience : MN·Jamil Ahsan Kazi, Mohamed Ibrahim Abu-Hassan
Jan 20, 2004·European Journal of Pharmacology·Patricia G da MottaMaria Aparecida K F Tatsuo
Jan 28, 2004·European Journal of Pharmacology·Teresa Mixcoatl-ZecuatlVinicio Granados-Soto
Apr 20, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·José Martínez-RagaGaspar Cervera
Oct 16, 2003·Trends in Pharmacological Sciences·Jon-Paul A ManningNorman G Bowery
Jun 17, 2000·European Journal of Pharmacology·W TimmermanB H Westerink
Aug 9, 2002·European Journal of Pharmacology·Johannes A van HooftWytse J Wadman
Jan 25, 2003·Pharmacology, Biochemistry, and Behavior·Zhang-Jin ZhangRobert M Post
Mar 15, 2003·Clinical Therapeutics·Miroslav Backonja, Robert L Glanzman
Jan 11, 2001·Pharmacology & Therapeutics·R D MacPherson
Jul 13, 2001·Pharmacology & Therapeutics·P KwanM J Brodie
Jun 5, 2003·Journal of Affective Disorders·Mauro Giovanni CartaBernardo Carpiniello
Aug 21, 2003·Progress in Neurobiology·Mark J Millan
Feb 25, 2000·Neuroscience Letters·G B AcostaC M Baratti
May 19, 2001·Neurologic Clinics·K D Holland
May 23, 2001·Journal of Pain and Symptom Management·N E SlatkinT M Bolton
Aug 23, 2001·Journal of Pain and Symptom Management·J DevulderJ M Naeyaert
Apr 16, 2003·Journal of Pain and Symptom Management·Ahmad Beydoun, Misha-Miroslav Backonja
Dec 12, 2001·Epilepsy Research·D OuelletE Garofalo
Jun 22, 2002·Epilepsy Research·Laura D ErranteOgnen A C Petroff
Nov 30, 2002·Epilepsy Research·Janet L Stringer, Ahmed M Aribi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.